Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
133.40    1.80 (1.37%)
Bid:
133.20
Ask:
133.80
Spread: 0.60 (0.45%)
Market Cap: £272.52m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

2023 Trading Update

24 Jan 2024 07:00

RNS Number : 6815A
Forterra plc
24 January 2024
 

24 January 2024

FORTERRA PLC

 

2023 Trading Update

 

Adjusted EBITDA expected to be slightly ahead of the Board's previous expectations

 

Forterra plc (the 'Group'), a leading UK manufacturer of essential clay and concrete building products, provides its trading update for the year ended 31 December 2023.

 

Trading

 

· Full year revenue totalled c.£345m (2022: £455m), a year-on-year reduction of c.24%, with the impact of falling sales volumes partially offset by pricing benefits.

 

· Despite weak demand, pricing across our range of products remains resilient with modest 2024 price increases recently communicated.

 

· Figures published by the Department of Business and Trade highlight that UK brick despatches in the three-month period to November were 33% lower than the equivalent period in 2022, taking the cumulative YTD reduction to approximately 30%. As highlighted previously, our own despatches fell by a greater percentage driven by our exposure to volume housebuilding which suffered the greatest impact from rising interest rates.

 

· Despite continued challenging market conditions we expect to report full year adjusted EBITDA slightly ahead of the Board's expectations.

 

Management Actions

 

· Strong management actions during the year will deliver annualised fixed costs savings in excess of £20m with around £6m realised in 2023 with the balance in 2024. One-off cash restructuring costs are expected to total £9m of which £4m will be paid in 2024.

 

· Faced with increasing inventory levels, we made further reductions to production during the second half of 2023 which, assuming 2024 demand remains consistent with 2023, will ensure output is aligned with sales.

 

· Production has been reduced through the mothballing of factories, shift reductions and production breaks. In addition, we have delivered further savings through restructuring commercial and back-office functions.

 

· These temporary reductions will not impact our ability to respond quickly when our markets recover, with the new Desford brick factory also providing us with a significant capacity uplift.

 

Balance Sheet

 

· Reflecting our inventory build, capital expenditure and the management actions taken during 2023, year-end net debt before leases is expected to be c.£95m.

 

Outlook

 

· The outlook for our industry remains subject to considerable uncertainty and, with a general election expected in 2024, demand is anticipated to remain subdued in the near term.

 

· However, with the long term under supply of housing in the UK continuing to worsen, and UK brick despatches now running at levels last seen in 2009, the Board remains confident in the Group's ability to benefit as our key markets recover.

 

· Recent reductions in mortgage interest rates will improve the affordability of new homes, thus increasing demand for our products.

 

· The Group intends to announce its FY23 results on 26 March 2024.

 

 

ENQUIRIES

 

 

Forterra plc

+44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting

+44 203 727 1340

Richard Mountain / Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOVWRSWUAUAR
Date   Source Headline
18th Mar 20227:00 amRNSTransaction in Own Shares
17th Mar 20225:14 pmRNSGrant under Performance Share Plan
17th Mar 20224:53 pmRNSGrant under Deferred Annual Bonus Plan
17th Mar 20224:51 pmRNSGrant under Deferred Annual Bonus Plan
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSTransaction in Own Shares
15th Mar 20227:00 amRNSTransaction in Own Shares
14th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20227:00 amRNSTransaction in Own Shares
10th Mar 20227:00 amRNSFinal Results
10th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:00 amRNSTransaction in Own Shares
8th Mar 20227:00 amRNSTransaction in Own Shares
7th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20227:00 amRNSTransaction in Own Shares
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20224:32 pmRNSEmployee Benefit Trust Share Purchase
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20225:00 pmRNSTotal Voting Rights
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20228:26 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSTransaction in Own Shares
11th Feb 20227:00 amRNSTransaction in Own Shares
10th Feb 20227:00 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:30 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSShare buyback programme
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20226:05 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20227:30 amRNSTransaction in Own Shares
31st Jan 20225:15 pmRNSTotal Voting Rights
31st Jan 20227:30 amRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:36 amRNSProgressive publishes new research
26th Jan 20227:00 amRNSPre-close trading update
6th Jan 20224:02 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20215:31 pmRNSEmployee Benefit Trust Share Purchase
25th Nov 20218:01 amRNSProgressive publishes new research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.